Compare KLXE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KLXE | DRIO |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1M | 52.8M |
| IPO Year | 2018 | 2013 |
| Metric | KLXE | DRIO |
|---|---|---|
| Price | $2.12 | $7.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 179.4K | 19.2K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $636,600,000.00 | $7,394,000.00 |
| Revenue This Year | $3.89 | $20.27 |
| Revenue Next Year | $4.95 | $47.58 |
| P/E Ratio | ★ N/A | $5.76 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $1.49 | $0.38 |
| 52 Week High | $4.50 | $17.74 |
| Indicator | KLXE | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 54.79 |
| Support Level | $2.04 | $7.18 |
| Resistance Level | $2.57 | $8.00 |
| Average True Range (ATR) | 0.18 | 0.66 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 17.74 | 68.81 |
KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.